Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Noxopharm Ltd
NOXCurrent price
0.11 AUD
+0.005 AUD (+4.76%)
Last closed
0.1 AUD
Company
www.noxopharm.com
ISIN
AU000000NOX9
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
28 941 169 AUD
Yield for 12 month
+197.30 %
1Y
3Y
5Y
10Y
15Y
NOX
Noxopharm Limited, a biotech company, discovers and develops treatments for cancer and inflammation, and mRNA vaccines in Australia. It primarily develops Veyonda, a formulation of idronoxil for the treatment of solid tumors. The company also develops LuPIN with combined therapy of Veyonda and 177Lu-PSMA-617 for the treatment of late-stage prostate cancer; and IONIC program with Veyonda, which is combined with the Bristol Myers Squibb checkpoint inhibitor Opdivo for the treatment of various solid tumor types. In addition, it develops NOXCOVID Program, a dose escalation and dose expansion study of NOX66 for the treatment of COVID-19 infection. Further, the company develops Chroma technology platform to develop CRO-67 dual-cell therapy drug for the treatment of pancreatic cancer and various molecules for the treatment of autoimmune disease and hyperinflammatory conditions; and Sofra platform that focuses on the development of immunomodulators for mRNA vaccines and mRNA therapeutics, as well as for the treatment of autoimmune diseases. The company was incorporated in 2015 and is based in Glenhaven, Australia. Address: 60 Linksley Avenue, Glenhaven, NSW, Australia, 2156
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.47 AUDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+5 951 961 AUD
Current Quarter
–
Last Quarter
+1 200 237 AUD
Current Year
-1 726 AUD
Last Year
+5 798 920 AUD
Current Quarter
-858 AUD
Last Quarter
+1 199 369 AUD
Key Figures NOX
1 year
3 years
5 years
10 years
EBITDA
-3 517 790 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-26.27 %
PEG Ratio
–
Return On Equity TTM
-49.12 %
Wall Street Target Price
1.47 AUD
Revenue TTM
3 414 700 AUD
Book Value
0.019 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-16.1 %
Dividend Yield
–
Gross Profit TTM
-4 591 657 AUD
Earnings per share
-0.0099 AUD
Diluted Eps TTM
-0.0099 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-103.77 %
Dividend Analytics NOX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NOX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation NOX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
8.4755
Enterprise Value EBITDA
-1.1582
Price Book MRQ
5.3181
Financials NOX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NOX
For 52 weeks
0.037 AUD
0.15 AUD
50 Day MA
0.086 AUD
Shares Short Prior Month
–
200 Day MA
0.074 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart